Rodin Therapeutics Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $950M
Latest Deal Amount

Rodin Therapeutics General Information

Description

Developer of epigenetic drugs intended to be used for the treatment of cognitive disorders and diseases of the brain. The company's epigenetic drugs are harnessing the power of epigenetic regulation of neuronal function by HDAC complex modulation, enabling patients to restore synaptic function, health and survival in degenerative brain diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Primary Office
  • 300 Technology Square
  • 8th Floor
  • Cambridge, MA 02139
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rodin Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 25-Nov-2019 $950M 000.00 00000 Completed Product Development
5. Grant 13-Nov-2017 00000 000.00 Completed Product Development
4. Early Stage VC 18-Sep-2017 0000 000.00 000.00 Completed Product Development
3. Early Stage VC 06-Jan-2016 000.00 000.00 Completed Startup
2. Early Stage VC (Series A) 29-May-2014 $12.9M $12.9M 000.00 Completed Startup
1. Seed Round 27-Jun-2013 Completed Startup
To view Rodin Therapeutics’s complete valuation and funding history, request access »

Rodin Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A3 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A2 1,649,147 $0.000100 5% $1.1 $1.1 1x $1.1 4.13%
Series A1 1,612,675 $0.000100 5% $1 $1 1x $1 4.04%
To view Rodin Therapeutics’s complete cap table history, request access »

Rodin Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of epigenetic drugs intended to be used for the treatment of cognitive disorders and diseases of the brain. Th
Drug Discovery
Cambridge, MA
000.00
0000 0000-00-00
000000&0 000.00

000000 0

abore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nis
0000 000000000
Cambridge, MA
00 As of 0000
000.00
0000 0000-00-00
000000&0 000.00

00000000

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
0000 000000000
Pittsburgh, PA
00 As of 0000
000.00
0000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rodin Therapeutics Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cadent Therapeutics Venture Capital-Backed Cambridge, MA 00 000.00 000000&0 000.00
000000000 00000000 Venture Capital-Backed Pittsburgh, PA 00 000.00 0000000000 000.00
0000000 Venture Capital-Backed Framingham, MA 00 000.00 0000000000 000.00
0000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
0000000 0000000000 Venture Capital-Backed Cambridge, MA 0 0000 00000000000 0000
You’re viewing 5 of 26 competitors. Get the full list »

Rodin Therapeutics Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alzheimers Drug Discovery Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Atlas Venture Venture Capital Minority 000 0000 000000 0
Biogen Corporation Minority 000 0000 000000 0
GV Corporate Venture Capital Minority 000 0000 000000 0
Hatteras Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »